Literature DB >> 15196023

Oligomeric assembly of native-like precursors precedes amyloid formation by beta-2 microglobulin.

Catherine M Eakin1, Frank J Attenello, Charles J Morgan, Andrew D Miranker.   

Abstract

The deposition of beta-2-microglobulin (beta2m) as amyloid fibers results in debilitating complications for renal failure patients who are treated by hemodialysis. In vitro, wild-type beta2m can be converted to amyloid under physiological conditions by exposure to biomedically relevant concentrations of Cu(2+). In this work, we have made comparative measurements of the structural and oligomeric changes in beta2m at time points preceding fibrillogenesis. Our results show Cu(2+) mediates the formation of a monomeric, activated state followed by the formation of a discrete dimeric intermediate. The dimeric intermediates then assemble into tetra- and hexameric forms which display little additional oligomerization on the time scales of their own formation (<1 h). Amyloid fiber formation progresses from these intermediate states but on much longer time scales (>1 week). Although Cu(2+) is necessary for the generation and stabilization of these intermediates, it is not required for the stability of mature amyloid fibers. This suggests that Cu(2+) acts as an initiating factor of amyloidosis by inducing oligomer formation. (1)H NMR and near-UV circular dichroism are used to establish that oligomeric intermediates are native-like in structure. The native-like structure and discrete oligomeric size of beta2m amyloid intermediates suggest that this protein forms fibrils by structural domain swapping.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196023     DOI: 10.1021/bi049792q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

1.  Domain swapping and amyloid fibril conformation.

Authors:  Patrick C A van der Wel
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

2.  The impact of solubility and electrostatics on fibril formation by the H3 and H4 histones.

Authors:  Traci B Topping; Lisa M Gloss
Journal:  Protein Sci       Date:  2011-11-09       Impact factor: 6.725

3.  Free energy landscapes for amyloidogenic tetrapeptides dimerization.

Authors:  A Baumketner; J-E Shea
Journal:  Biophys J       Date:  2005-09       Impact factor: 4.033

4.  Amyloid fibril formation can proceed from different conformations of a partially unfolded protein.

Authors:  Martino Calamai; Fabrizio Chiti; Christopher M Dobson
Journal:  Biophys J       Date:  2005-09-16       Impact factor: 4.033

5.  Structural insights into a yeast prion illuminate nucleation and strain diversity.

Authors:  Rajaraman Krishnan; Susan L Lindquist
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  Probing the functional heterogeneity of surface binding sites by analysis of experimental binding traces and the effect of mass transport limitation.

Authors:  Juraj Svitel; Hacène Boukari; Donald Van Ryk; Richard C Willson; Peter Schuck
Journal:  Biophys J       Date:  2006-12-08       Impact factor: 4.033

Review 7.  The structural biology of protein aggregation diseases: Fundamental questions and some answers.

Authors:  David Eisenberg; Rebecca Nelson; Michael R Sawaya; Melinda Balbirnie; Shilpa Sambashivan; Magdalena I Ivanova; Anders Ø Madsen; Christian Riekel
Journal:  Acc Chem Res       Date:  2006-09       Impact factor: 22.384

8.  X-ray Crystallographic Structures of Oligomers of Peptides Derived from β2-Microglobulin.

Authors:  Ryan K Spencer; Adam G Kreutzer; Patrick J Salveson; Hao Li; James S Nowick
Journal:  J Am Chem Soc       Date:  2015-05-12       Impact factor: 15.419

9.  Structure of the preamyloid dimer of beta-2-microglobulin from covalent labeling and mass spectrometry.

Authors:  Vanessa Leah Mendoza; Kwasi Antwi; Mario A Barón-Rodríguez; Cristian Blanco; Richard W Vachet
Journal:  Biochemistry       Date:  2010-02-23       Impact factor: 3.162

Review 10.  Lessons learned from protein aggregation: toward technological and biomedical applications.

Authors:  César L Avila; Silvina Chaves; Sergio B Socias; Esteban Vera-Pingitore; Florencia González-Lizárraga; Cecilia Vera; Diego Ploper; Rosana Chehín
Journal:  Biophys Rev       Date:  2017-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.